It is interesting to notice that all 9 CN-LOHs were present in the LAM patients with single TSC1/2 mutations, but absent in the LAM patients with 2 or more TSC1/2 mutations or without detectable TSC1/2 mutations (S5 Table) (P<0. Here, TSC1 is linked to lymphangioleiomyomatosis.